We are live on ! Find out more
CI

Capital International Portfolio holdings

AUM $2.7B
1-Year Est. Return 31.08%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+31.08%
3 Year Est. Return
+123.92%
5 Year Est. Return
+171.61%
10 Year Est. Return
+862.17%
AUM
$2.09B
AUM Growth
+$141M
Cap. Flow
-$59.7M
Cap. Flow %
-2.86%
Top 10 Hldgs %
31.73%
Holding
160
New
7
Increased
95
Reduced
34
Closed
13

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$18.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$6.66M
3
SNPS icon
Synopsys
SNPS
+$6.48M
4
SLB icon
SLB Ltd
SLB
+$6.36M
5
AAPL icon
Apple
AAPL
+$6.32M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$40.1M
2
LLY icon
Eli Lilly
LLY
+$19.6M
3
AMAT icon
Applied Materials
AMAT
+$16.9M
4
AVGO icon
Broadcom
AVGO
+$16.7M
5
ZTS icon
Zoetis
ZTS
+$15.6M

Sector Composition

Rank Sector Weight
1 Technology 25.33%
2 Healthcare 15.83%
3 Consumer Discretionary 13.32%
4 Communication Services 12.19%
5 Industrials 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
B
151
Barrick Mining
B
$68.8B
-22,325
Closed -$404K
HES
152
DELISTED
Hess
HES
-15,985
Closed -$2.3M
IDXX icon
153
Idexx Laboratories
IDXX
$46.1B
-22,771
Closed -$12.6M
IFF icon
154
International Flavors & Fragrances
IFF
$22.5B
-54,708
Closed -$4.43M
MCO icon
155
Moody's
MCO
$83.8B
-27,640
Closed -$10.8M
MOS icon
156
The Mosaic Company
MOS
$7.44B
-86,315
Closed -$3.08M
MSCI icon
157
MSCI
MSCI
$41.6B
-1,627
Closed -$920K
PODD icon
158
Insulet
PODD
$9.23B
-32,342
Closed -$7.02M
TNDM icon
159
Tandem Diabetes Care
TNDM
$1.34B
-55,912
Closed -$1.65M
KRTX
160
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-18,241
Closed -$5.77M

Similar funds

Capital International's Q1 2024 Portfolio in Review

As of Q1 2024, Capital International held 160 positions worth $2.09B, up 7.2% from $1.95B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Capital International's Q1 2024 filing shows 7 new, 95 increased, 34 reduced and 13 closed positions. Its largest new stake was Boston Scientific: 63,706 shares worth $4.36M. The largest sale was Microsoft, an estimated $40.1M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital International's largest Q1 2024 buy was Boston Scientific: 63,706 shares worth $4.36M.
  • Capital International added most to Amazon in Q1 2024, an estimated $18.4M increase.
  • Capital International's biggest Q1 2024 reduction was Microsoft, cutting an estimated $40.1M.
  • Capital International fully exited Idexx Laboratories in Q1 2024, selling an estimated $12.6M.
  • Capital International's ten largest holdings make up 32% of its $2.09B portfolio in Q1 2024.
  • Capital International opened 7 new positions and closed 13 in Q1 2024.
  • Capital International's portfolio value rose 7.2% quarter-over-quarter to $2.09B.

Based on Capital International's 13F filing for Q1 2024, filed 14 May 2024.